Article
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Journal of hypertension - 1 Apr 2002
Kurland Lisa, Melhus Håkan, Karlsson Julia, Kahan Thomas, Malmqvist Karin, Ohman Peter, Nyström Fredrik, Hägg Anders, Lind Lars
Abstract excerpt
BACKGROUND: Our aim was to determine if gene polymorphisms in the renin-angiotensin-aldosterone system (RAAS) were related to the degree of change in left ventricular hypertrophy (LVH) during antihypertensive treatment. METHODS AND RESULTS: Patients with essential hypertension and echocardiographically diagnosed LVH were included in a double-blind study to receive treatment with either the angiotensin II type 1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.